Citigroup’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
8,930
-781
| -8% | -$22.9K | ﹤0.01% | 3225 |
|
|
2025
Q1 | $250K | Sell |
9,711
-7,742
| -44% | -$199K | ﹤0.01% | 3308 |
|
|
2024
Q4 | $504K | Buy |
17,453
+8,306
| +91% | +$240K | ﹤0.01% | 3020 |
|
|
2024
Q3 | $217K | Sell |
9,147
-9,318
| -50% | -$221K | ﹤0.01% | 3521 |
|
|
2024
Q2 | $319K | Buy |
18,465
+17,715
| +2,362% | +$306K | ﹤0.01% | 2944 |
|
|
2024
Q1 | $16.7K | Buy |
750
+170
| +29% | +$3.8K | ﹤0.01% | 4331 |
|
|
2023
Q4 | $10.6K | Buy |
580
+475
| +452% | +$8.71K | ﹤0.01% | 4421 |
|
|
2023
Q3 | $1.82K | Sell |
105
-1,228
| -92% | -$21.3K | ﹤0.01% | 4232 |
|
|
2023
Q2 | $24.3K | Buy |
1,333
+1,238
| +1,303% | +$22.5K | ﹤0.01% | 4233 |
|
|
2023
Q1 | $1.62K | Sell |
95
-10,070
| -99% | -$172K | ﹤0.01% | 4392 |
|
|
2022
Q4 | $236K | Buy |
10,165
+10,051
| +8,817% | +$234K | ﹤0.01% | 2959 |
|
|
2022
Q3 | $3K | Sell |
114
-491
| -81% | -$12.9K | ﹤0.01% | 4631 |
|
|
2022
Q2 | $12K | Buy |
605
+264
| +77% | +$5.24K | ﹤0.01% | 4570 |
|
|
2022
Q1 | $12K | Sell |
341
-488
| -59% | -$17.2K | ﹤0.01% | 4673 |
|
|
2021
Q4 | $72K | Buy |
829
+559
| +207% | +$48.6K | ﹤0.01% | 4139 |
|
|
2021
Q3 | $31K | Buy |
+270
| New | +$31K | ﹤0.01% | 4264 |
|